Intravenous ketamine in adult patients with treatment-resistant depression
Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Nueten LV. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in adult patients with treatment-resistant depression. Am J Psychiatry (in press).